[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100400829":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":49,"collaborators":51,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":24,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":24,"enrollmentInfo":63,"targetDuration":24,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":74,"overallStatus":39,"whyStopped":24,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Barts & The London NHS Trust","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention","EXPERIMENTAL","Patients undergoing catheter ablation of VT",[13],"Other: Validated quality of life questionnaire (EQ-5D & C-CAP)",{"label":15,"type":16,"description":17,"interventionNames":18},"Comparator","ACTIVE_COMPARATOR","Patients undergoing AAD therapy for VT",[13],[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"Validated quality of life questionnaire (EQ-5D & C-CAP)","Patient quality of life to be assessed at baseline, 1, 2, 3, 4, 6, 9 and 12 months",[15,9],null,[26],{"name":27,"affiliation":28,"role":29},"Pier Lambiase, PhD","UCL","STUDY_CHAIR",[31],{"name":32,"role":33,"phone":34,"phoneExt":24,"email":35},"Yang Chen, BM BCh","CONTACT","02034165000","yang.chen@nhs.net",[37],{"facility":38,"status":39,"city":40,"state":24,"zip":24,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":24},"St Bartholomew's Hospital","RECRUITING","London","United Kingdom","UK",{"type":44,"coordinates":45},"Point",[46,47],-0.12574,51.50853,{"lat":47,"lon":46},{"type":50,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[52],{"name":53,"class":6},"University College, London","100400829","improving-patient-reported-outcome-measures-in-catheter-ablation-100400829",false,"NCT04499326","Improving Patient Reported Outcome Measures in Catheter Ablation","Use of Patient Reported Outcome Measures (PROMs) to Assess Quality of Life and Economic Evaluation of Cardiac Catheter Ablation of Ventricular Tachycardia: a Feasibility and Cohort Study","Inclusion Criteria:\n\nAdults (\\>18 years) With an Implantable Cardioverter Defibrillator (ICD) implanted \\>3 months from time of recruitment and a previous episode of documented VT requiring therapy from the ICD.\n\nAnd impaired LV\u002FRV function Willing and able to give written informed consent\n\nExclusion Criteria:\n\nPatients who are planning to move away from study site within 12 months of enrolment who wished to use postal method to complete their HRQL Patients who are unable to give informed consent","ALL","18 Years",{"count":64,"type":65},70,"ESTIMATED","INTERVENTIONAL",[68],"NA","This study will assess whether more frequent measurement of patient reported outcome measures (PROMs) - specifically health related quality of life (HRQL) - can improve the evaluation of the clinical effectiveness and cost-effectiveness of catheter ablation of ventricular tachycardia (VT) in patients with an Implantable Cardioverter Defibrillator (ICD).\n\nIt is designed to have feasibility outcomes which contribute to answering the above.",[71,72,73],"Ventricular Tachycardia","ICD","Quality of Life",[75,76,77],"Catheter ablation","Patient reported outcome measure","Incremental cost effectiveness ratio","2026-02-26",{"date":80,"type":81},"2026-03-02","ACTUAL",{"date":83,"type":81},"2024-06-13",{"date":85,"type":65},"2026-12-31",{"name":5,"class":6},1]